Retrieve available abstracts of 19 articles: HTML format
Single Articles
May 2025
GILMORE LA, Willmann J, Olaechea S, Gilmore BW, et al Prevalence and Development of Cachexia Before and After Diagnosis of Non-small
Cell Lung Cancer.
Am J Clin Oncol. 2025 May 5. doi: 10.1097/COC.0000000000001211. PubMedAbstract available
December 2024
SANCHEZ JI, Doose M, Zeruto C, Chollette V, et al Assessing the Impact of Multidisciplinary Cancer Consultations on Cancer Quality
Metrics.
Am J Clin Oncol. 2024;47:595-606. PubMedAbstract available
November 2024
SHAH A, Apple J, Aslam S, Engel-Nitz NM, et al Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by
Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic
Nonsmall-cell Lung Cancer.
Am J Clin Oncol. 2024 Nov 5. doi: 10.1097/COC.0000000000001155. PubMedAbstract available
October 2024
GUMUSTEPE E, Yavas G, Kirakli EK, Dincbas FO, et al Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III
Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation
Oncology Thoracic Cancer Study Group (08-005).
Am J Clin Oncol. 2024 Oct 22. doi: 10.1097/COC.0000000000001152. PubMedAbstract available
September 2024
QURESHI Z, Altaf F, Jamil A, Siddique R, et al Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer:
Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line
Treatment.
Am J Clin Oncol. 2024 Sep 11. doi: 10.1097/COC.0000000000001138. PubMedAbstract available
June 2024
LIU C, Gao F, Yang J, Liu C, et al Wilms' Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the
Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.
Am J Clin Oncol. 2024 Jun 20. doi: 10.1097/COC.0000000000001116. PubMedAbstract available
XU J, Tian L, Qi W, Lv Q, et al Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.
Am J Clin Oncol. 2024;47:291-303. PubMedAbstract available
May 2024
ZHANG T, Hu Y, Yang N, Yu S, et al The microRNA-34 Family and Its Functional Role in Lung Cancer.
Am J Clin Oncol. 2024 May 3. doi: 10.1097/COC.0000000000001106. PubMedAbstract available
KASHIWABARA K, Fujii S, Tsumura S, Tokunaga R, et al Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in
Elderly Patients With Malignant Central Airway Obstruction: A Retrospective
Single-institution Study.
Am J Clin Oncol. 2024;47:223-227. PubMedAbstract available
April 2024
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict
Aggressive Behavior: Erratum.
Am J Clin Oncol. 2024;47:e1. PubMed
LIU X, Shen Q, Wen Y, Jiang Z, et al Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated
Autoantibodies and Computed Tomography.
Am J Clin Oncol. 2024;47:149-154. PubMedAbstract available
January 2024
CHOU B, Lee JH, Saetern L, Venkatesulu BP, et al Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With
Oligoprogressive Non-Small Cell Lung Cancer on Maintenance Systemic Therapy.
Am J Clin Oncol. 2024 Jan 9. doi: 10.1097/COC.0000000000001077. PubMedAbstract available
December 2023
BRASCHI EL, Morris CG, Yeung AR, De Leo AN, et al Impact of Maximum Point Dose Within the Planning Target Volume on Local Control
of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
Am J Clin Oncol. 2023 Dec 25. doi: 10.1097/COC.0000000000001081. PubMedAbstract available
November 2023
ALVAREZ CM, Aliru M, Gannavarapu BS, Song T, et al Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical
Outcomes in Non-Small Cell Lung Cancer.
Am J Clin Oncol. 2023 Nov 24. doi: 10.1097/COC.0000000000001053. PubMedAbstract available
YANG L, Lu X, Luo J, Huang D, et al Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy
in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair
Analysis.
Am J Clin Oncol. 2023 Nov 20. doi: 10.1097/COC.0000000000001066. PubMedAbstract available
CANTRELL JN, Acharya P, Vesely SK, Gunter TC, et al Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact
Overall Survival: A Propensity Score-matched NCDB Analysis.
Am J Clin Oncol. 2023;46:503-511. PubMedAbstract available
October 2023
ZHAO KX, Zhang YF, Zheng L, Pan YF, et al A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as
Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer
With Epidermal Growth Factor Receptor Mutation.
Am J Clin Oncol. 2023 Oct 2. doi: 10.1097/COC.0000000000001047. PubMedAbstract available
September 2023
YU S, Zhai S, Gong Q, Xiang C, et al Neoadjuvant Immunotherapy and Non-Small Cell Lung Cancer: A Systematic Review and
Meta-analysis of Randomized Controlled Trials.
Am J Clin Oncol. 2023 Sep 26. doi: 10.1097/COC.0000000000001046. PubMedAbstract available
ACIKGOZ Y, Yildirim FU, Esen SA, Ucar G, et al The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell
Lung Cancer.
Am J Clin Oncol. 2023 Sep 13. doi: 10.1097/COC.0000000000001044. PubMedAbstract available